Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis

P. Wohl, T. Hucl, P. Drastich, D. Kamenar, J. Spicak, E. Honsova, E. Sticova, A. Lodererova, J. Matous, M. Hill, P. Wohl, M. Kucera,

. 2013 ; 19 (14) : 2234-41.

Language English Country Taiwan

Document type Journal Article, Research Support, Non-U.S. Gov't

AIM: To evaluate the expression of epithelial markers of colorectal carcinogenesis in patients with long-term ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) before and after transplantation. METHODS: Eight patients with UC and PSC prior to liver transplantation (PSC-UC), 22 patients with UC after liver transplantation for PSC (OLT), 9 patients with active ulcerative colitis without PSC (UCA), 7 patients with UC in remission (UCR) and 10 controls (N) underwent colonoscopy with multiple biopsies. Specimens were analysed histologically and semi-quantitatively immunohistochemically for p53, Bcl-2 and cyclooxygenase-2 (COX-2) markers. Statistical analysis was performed by Kruskal-Wallis and Fisher's exact tests. RESULTS: PSC-UC had a statistically significantly higher expression of p53 in the nondysplastic mucosa as compared to OLT, UCA, UCR and N (P < 0.05). We also found a statistically significant positive correlation between the incidence of PSC and the expression of p53 (P < 0.001). UCA had a higher p53 expression as compared to UCR. OLT had a significantly lower expression of p53 as compared with PSC-UC (P < 0.001). Bcl-2 had a significant higher bcl-2 expression as compared with controls. No difference in COX-2 expression between PSC-UC, UCR and UCA was found. UCA had higher COX-2 expression as compared to UCR. We also found a statistically significant positive correlation between the expression of COX-2 and p53. Patients after liver transplantation for PSC had a statistically significantly lower expression of the p53 compared with PSC-UC (P < 0.001). PSC-UC had the same inflammatory endoscopic activity as OLT and UCR when evaluated with the Mayo score. CONCLUSION: Our study shows that the nondysplatic mucosa of UC patients with PSC is characterised by a higher expression of the tumour suppressor gene p53, suggesting a higher susceptibility of cancer. This p53 overexpression correlates with the presence of PSC whilst it is not present in patients with UC after liver transplantation for PSC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14040791
003      
CZ-PrNML
005      
20140110112817.0
007      
ta
008      
140107s2013 ch f 000 0|eng||
009      
AR
024    7_
$a 10.3748/wjg.v19.i14.2234 $2 doi
035    __
$a (PubMed)23599650
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ch
100    1_
$a Wohl, Pavel
245    10
$a Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis / $c P. Wohl, T. Hucl, P. Drastich, D. Kamenar, J. Spicak, E. Honsova, E. Sticova, A. Lodererova, J. Matous, M. Hill, P. Wohl, M. Kucera,
520    9_
$a AIM: To evaluate the expression of epithelial markers of colorectal carcinogenesis in patients with long-term ulcerative colitis (UC) and primary sclerosing cholangitis (PSC) before and after transplantation. METHODS: Eight patients with UC and PSC prior to liver transplantation (PSC-UC), 22 patients with UC after liver transplantation for PSC (OLT), 9 patients with active ulcerative colitis without PSC (UCA), 7 patients with UC in remission (UCR) and 10 controls (N) underwent colonoscopy with multiple biopsies. Specimens were analysed histologically and semi-quantitatively immunohistochemically for p53, Bcl-2 and cyclooxygenase-2 (COX-2) markers. Statistical analysis was performed by Kruskal-Wallis and Fisher's exact tests. RESULTS: PSC-UC had a statistically significantly higher expression of p53 in the nondysplastic mucosa as compared to OLT, UCA, UCR and N (P < 0.05). We also found a statistically significant positive correlation between the incidence of PSC and the expression of p53 (P < 0.001). UCA had a higher p53 expression as compared to UCR. OLT had a significantly lower expression of p53 as compared with PSC-UC (P < 0.001). Bcl-2 had a significant higher bcl-2 expression as compared with controls. No difference in COX-2 expression between PSC-UC, UCR and UCA was found. UCA had higher COX-2 expression as compared to UCR. We also found a statistically significant positive correlation between the expression of COX-2 and p53. Patients after liver transplantation for PSC had a statistically significantly lower expression of the p53 compared with PSC-UC (P < 0.001). PSC-UC had the same inflammatory endoscopic activity as OLT and UCR when evaluated with the Mayo score. CONCLUSION: Our study shows that the nondysplatic mucosa of UC patients with PSC is characterised by a higher expression of the tumour suppressor gene p53, suggesting a higher susceptibility of cancer. This p53 overexpression correlates with the presence of PSC whilst it is not present in patients with UC after liver transplantation for PSC.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a biopsie $7 D001706
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a sklerozující cholangitida $x etiologie $x metabolismus $x chirurgie $7 D015209
650    _2
$a ulcerózní kolitida $x komplikace $x metabolismus $x chirurgie $7 D003093
650    _2
$a kolonoskopie $7 D003113
650    _2
$a kolorektální nádory $x chemie $x etiologie $7 D015179
650    _2
$a cyklooxygenasa 2 $x analýza $7 D051546
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a transplantace jater $7 D016031
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a protoonkogenní proteiny c-bcl-2 $x analýza $7 D019253
650    _2
$a výsledek terapie $7 D016896
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a nádorový supresorový protein p53 $x analýza $7 D016159
650    _2
$a upregulace $7 D015854
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hucl, Tomas $u -
700    1_
$a Drastich, Pavel $u -
700    1_
$a Kamenar, David $u -
700    1_
$a Spicak, Julius $u -
700    1_
$a Honsova, Eva $u -
700    1_
$a Sticova, Eva $u -
700    1_
$a Lodererova, Alena $u -
700    1_
$a Matous, Jan $u -
700    1_
$a Hill, Martin $u -
700    1_
$a Wohl, Petr $u -
700    1_
$a Kucera, Milos $u -
773    0_
$w MED00006918 $t World journal of gastroenterology : WJG $x 1007-9327 $g Roč. 19, č. 14 (2013), s. 2234-41
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23599650 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140107 $b ABA008
991    __
$a 20140110113518 $b ABA008
999    __
$a ok $b bmc $g 1005187 $s 839303
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 19 $c 14 $d 2234-41 $i 1007-9327 $m World journal of gastroenterology $n World J Gastroenterol $x MED00006918
LZP    __
$a Pubmed-20140107

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...